Determination of receptor and HER2 status of breast cancer using tissue matrix technology. Validation of the method. Вопр. онкол. [Internet]. 2016 Dec. 15 [cited 2026 Oct. 14];62(2):314-9. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/263